The Cell and Gene Therapy Access Model

This Viewpoint discusses lessons learned from the first negotiation cycle of the Centers for Medicare & Medicaid Services’ Cell and Gene Therapy Access Model.

Corresponding Author: Melissa Majerol, MPH, Centers for Medicare melissa.majerol@cms.hhs.gov).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.